Collecting blood and tissue samples during bladder cancer surgery
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study collects clinical and tissue samples from people who are having surgery for bladder cancer and related urinary-tract tumors. It aims to improve understanding of cancer and may help future care by building a large research dataset.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 90 years old
- Be having planned surgeries for bladder cancer (TURBT and/or cystectomy)
- Be willing to have tumor biopsy and/or tumor removal for sampling
- Have planned surgery to remove metastases (spread cancer), when applicable
- Agree to informed consent for collecting your clinical and pathology information
- Not be pregnant (or have a pregnancy concern)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the outcomes of bladder removal surgery (radical cystectomy) for people with bladder cancer. It may help doctors understand how well this treatment works in Korean patients.
This study collects your medical information and tissue/biologic samples before bladder surgery. The goal is to better study specific types of bladder cancer, which may help future diagnosis and treatment decisions.
This study collects urine and tissue samples from people being checked for blood in their urine (hematuria) to build a 'bladder bank' for future research. By donating samples, you help scientists learn more about bladder conditions and improve diagnosis.
This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.
This study looks at how fluid absorbed during bladder cancer removal surgery affects cell-free DNA (tiny pieces of cancer DNA) in your blood. Researchers want to understand if these blood markers can help predict surgery outcomes and guide treatment decisions.
This study looks at urothelial cancer (often bladder cancer) samples taken during diagnosis or standard treatment. It may help researchers better understand the disease by using tissue that doctors already need to collect for care.
Hear when a new Urinary Bladder Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.